William Hoffman - Jan 4, 2022 Form 4/A - Amendment Insider Report for Inari Medical, Inc. (NARI)

Role
President and CEO, Director
Signature
/s/ Angela Ahmad, attorney-in-fact for William Hoffman
Stock symbol
NARI
Transactions as of
Jan 4, 2022
Transactions value $
$12,091
Form type
4/A - Amendment
Date filed
2/9/2022, 06:52 PM
Date Of Original Report
Jan 6, 2022
Previous filing
Jan 4, 2022
Next filing
Feb 9, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NARI Common Stock Options Exercise $12.1K +28.2K +5.54% $0.43* 539K Jan 4, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NARI Stock Options (Right to buy) Options Exercise $0 -28.2K -10.92% $0.00 230K Jan 4, 2022 Common Stock 28.2K $0.43 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 16, 2021.
F2 Option vested with respect to 25% of the underline shares on May 3, 2019 and vest with respect to the remaining shares in 36 equal monthly installments thereafter.

Remarks:

This amended Form 4 is being filed solely to show that the shares acquired were sold as reported in previously filed Form 4s.